Graduates of the Department of Pharmacology and Toxicology
| # | Graduate | Degree | Year | Mentor (s) | Dissertation/Thesis Title (electronic versions) |
|---|---|---|---|---|---|
| 399 | Kennedy M. Walls | Ph.D. | 2023 | David W. Hein, Ph.D. & Kyung U. Hong, Ph.D. | Investigation of heterocyclic amines and N-acetyltransferase 2 genetic polymorphism in the dysregulation of hepatic energy homeostasis: A gene-environment approach |
| 398 | Sarah H. Shrader | Ph.D. | 2023 | Zhao-Hui (Joe) Song, Ph.D. & Gregory N. Barnes, M.D., Ph.D. | Cannabidiol, behavior & the immune system in idiopathic autism spectrum disorder |
| 397 | Tyler C. Gripshover | Ph.D. | 2023 | Matthew C. Cave, M.D. | The impact of environmental pollutants on alcohol-associated liver disease pathogenesis |
| 396 | Caitlin C. Wilkerson | M.S. | 2023 | Walter H. (Bert) Watson, Ph.D. | Ethanol dysregulates Sirt1-mediated lipogenic signaling pathways through α4*-nicotinic acetylcholine receptors in hepatocytes |
| 395 | Samuel T. Vielee | M.S. | 2023 | Johnny Wise Jr., Ph.D. & John P. Wise, Sr., Ph.D. | Using a toxic aging coin to assess hexavalent chromium-induced neurotoxicity |
| 394 | Daniel C. Gomes | M.S. | 2023 | Timothy O'Toole, Ph.D. | Environmental exposures and aging |
| 393 | Dakota D. Cathey | M.S. | 2023 | Lu Cai, M.D., Ph.D. & Jiapeng Huang, M.D., Ph.D. | Study of the effects of chronic cadmium exposure on the pathogenesis of pulmonary arterial hypertension |
| 392 | Raphael Jigo | M.S. | 2023 | Geoffrey J. Clark, Ph.D. | Inhibition of RALGDS as a therapeutic approach in NSCLC |
| 391 | Dana Hammouri | M.S. | 2023 | Tamer M.A. Mohamed, Ph.D. | KDM5B as a potential epigenetic regulator of cardiomyocyte regeneration and cell cycle activation |
| 390 | Ngozi V. Adiele | M.S. | 2023 | Matthew C. Cave, M.D. | The effects of environmental pollutants on liver disease: role of the gut-liver axis |
| 389 | Jeffrey B. Warner | Ph.D. | 2023 | Irina A. Kirpich, Ph.D. | Soluble epoxide hydrolase inhibition: A novel therapeutic strategy for alcohol-associated liver disease |
| 388 | Micaela A. Reeves | Ph.D. | 2023 | Nobuyuki Matoba, Ph.D. | EPICERTIN: preclinical development of a novel mucosal healing agent |
| 387 | Andrew J. Orwick | Ph.D. | 2023 | Leah Siskind, Ph.D. & Levi Beverly, Ph.D. | Lung cancer-kidney crosstalk prevents protection from 5-hydroxytryptamine 1F receptor agonist in repeated low dose cisplatin induced nephrotoxicity |
| 386 | Sean M. Raph | Ph.D. | 2022 | Matthew A. Nystoriak, Ph.D. | Voltage gated potassium channel dependent mechanisms of cardiovascular adaptation to chronic exercise |
| 385 | Nagwa El-Baz | Ph.D. | 2022 | Martin G. O'Toole, Ph.D. | The impact of pegylation on cellular uptake and in vivo biodistribution of gold nanoparticle MRI contrast agents |
| 384 | Breandon S. Taylor | M.S. | 2022 | Sanjay Srivastava, Ph.D. | The impact of volatile organic compound exposure on subclinical biomarkers of cardiovascular injury |
| 383 | Mariam R. Habil | Ph.D. | 2022 | David W. Hein, Ph.D. | Investigation of human N-acetyltransferases (NAT1 and NAT2) genetic polymorphisms in susceptibility to aromatic amine and alkylaniline genotoxicity |
| 382 | Samantha A. McFall | M.S. | 2022 | Sanjay Srivastava, Ph.D. | The effect of volatile organic compounds on endothelial function and atherogenesis |
| 381 | Kate Tarvestad | M.S. | 2022 | Brian P. Ceresa, Ph.D. | HGF-mediated c-Met signaling in human corneal epithelial cells |
| 380 | Haiyan Lu | Ph.D. | 2022 | John P. Wise, Sr., Ph.D. | Translating particulate hexavalent chromium-induced chromosome instability from human lung cells to experimental animals, human lung tumors, and whale cells |
| 379 | Alyssa S. Aebersold | Ph.D. | 2022 | Zhao-hui (Joe) Song, Ph.D. | Application of cannabidiol to occular pharmacokinetics and pharmacodynamics |
| 378 | Andre D. Richardson | Ph.D. | 2022 | Daniel J. Conklin, Ph.D. | Tobacco-derived aldehydes, platelets and thrombogenicity: Role of transient receptor potential ankyyrin-1 |
| 377 | Jennifer H. Toyoda | Ph.D. | 2022 | John P. Wise, Sr., Ph.D. | Molecular mechanisms of hexavalent chromium-induced centrosome amplification |
| 376 | Hunter A. Miller | Ph.D. | 2022 | Hermann B. Frieboes, Ph.D. | A modeling platform to predict cancer survival and therapy outcomes using tumor tissue derived metabolomics data |
| 375 | Aaron G. Whitt | Ph.D. | 2022 | Chi Li, Ph.D. | The roles of PON2 in mitochondrial physiology, lung tumor cell proliferation, and lung tumorigenesis |
| 374 | Mengwei Jiang | Ph.D. | 2022 | Wenke Feng, Ph.D. | Extracellular vesicles from Lactobacillus rhamnosus GG protect against alcohol-induced liver injury through suppression of intestinal miR194 and subsequent activation of FXR in mice |
| 373 | Aggie R. Williams | M.S. | 2022 | John P. Wise, Sr., Ph.D. | Particulate hexavalent chromium inhibits homologous recombination repair by targeting RAD51 paralogs in human lung fibroblasts |
| 372 | Lucy J. Sloan | M.S. | 2022 | Zhao-hui (Joe) Song, Ph.D. & Shigeo Tamiya, Ph.D. | Cannabinoids and retinal fibrotic disorders |
| 371 | Angeliki Lykoudi | M.S. | 2021 | J. Christopher States, Ph.D. | Assessing the role of arsenic exposure and miRNA-186 in skin tumorigenesis and chromosomal instability |
| 370 | Matthew W. Dent | Ph.D. | 2021 | Nobuyuki Matoba, Ph.D. | Preclinical development of Avaren-FC: A novel lectin-FC fusion protein targeting cancer-associated high-mannose glycans |
| 369 | Nicholas A. Hoffman | M.S. | 2021 | Leah Siskind, Ph.D. | The role of sphingolipids in AKI and the progression to CKD: potential therapeutic targets |
| 368 | Idoia Meaza Isusi | M.S. | 2021 | John P. Wise, Sr., Ph.D. | Translating particulate Cr(VI)-induced chromosome instability, loss of homologous recombination repair and targeting of RAD51 from human lung fibroblasts to bronchial epithelial cells |
| 367 | Sophia M. Sears | Ph.D. | 2021 | Leah Siskind, Ph.D. & Levi Beverly, Ph.D. | Characterizing the role of macrophages in cisplatin-induced kidney injury and progression to chronic kidney disease |
| 366 | Marc M. Dwenger | Ph.D. | 2021 | Matthew A. Nystoriak, Ph.D. | Pyridine nucleotide redox potential in coronary smooth muscle couples myocardial blood flow to cardiac metabolism |
| 365 | Srineil Bodduluri | M.S. | 2021 | Shirish Barve, Ph.D. | Histone deacetylases in alcohol associated liver disease |
| 364 | George Z. Wei | Ph.D. | 2021 | Scott R. Whittemore, Ph.D. & Michal Hetman, M.D., Ph.D. | Oligodendrocyte responses after spinal cord injury |
| 363 | Tyler C. Gripshover | M.S. | 2021 | Matthew C. Cave, M.D. | Investigating the effects of perfluorooctanoic sulfonate (PFOS) and ethanol on fatty liver disease using a modified NIAAA model |
| 362 | Andrew J. Orwick | M.S. | 2021 | Leah Siskind, Ph.D. & Levi Beverly, Ph.D. | The role of PGC-1α in repeated low-dose cisplatin-induced kidney injury and the progression to chronic kidney disease |
| 361 | Kennedy M. Walls | M.S. | 2021 | David W. Hein, Ph.D. & Kyung U. Hong, Ph.D. | Heterocyclic amines and arylamine N-acetyltransferase 2 polymorphism in pathogenesis of insulin resistance |
| 360 | Austin M. Krueger | M.S. | 2021 | Leah Siskind, Ph.D. & Levi Beverly, Ph.D. | Characterizing the role of Src in NSCLC cell and fibroblast migration on 3D cell-derived matrix |
| 359 | Micaela A. Reeves | M.S. | 2021 | Nobuyuki Matoba, Ph.D. | Preclinical development of Epicertin, a novel biotherapeutic for the treatment of ulcerative colitis |
| 358 | Mohamed A. Elnagdy | M.S. | 2021 | Leila Gobejishvili, Ph.D. | PDE4 inhibition: A novel therapeutic strategy of liver fibrosis |
| 357 | Sean M. Raph | M.S. | 2021 | Matthew A. Nystoriak, Ph.D. | Myocardial blood flow control by oxygen sensing vascular KVβ proteins |
| 356 | Christine Kim | Ph.D. | 2021 | Brian P. Ceresa, Ph.D. | Assessing the role of arsenic in the EGFR signaling axis |
| 355 | Jamie L. Young | Ph.D. | 2020 | Lu Cai, M.D., Ph.D. | The effects of whole life, low dose cadmium exposure on high fat diet-induced NAFLD and the role of zinc |
| 354 | Jian (Joseph) Jin | Ph.D. | 2020 | Matthew C. Cave, M.D. | Effects of polychlorinated biphenyls on nonalcoholic fatty liver disease: Role of the aryl hydrocarbon receptor |
| 353 | Jeffrey B. Warner | M.S. | 2020 | Irina A. Kirpich, Ph.D. | Soluble expoxide hydrolase inhibition: A novel therapeutic strategy in alcoholic liver disease |
| 352 | Rachel M. Speer | Ph.D. | 2020 | John P. Wise, Sr., Ph.D. | Mechanisms of chromate-induced suppression of RAD51: A one environmental health approach |
| 351 | Mariam R. Habil | M.S. | 2020 | David W. Hein, Ph.D. | N-Acetyltransferase 2 (NAT2) genotype polymorphism in cryopreserved human hepatocytes and Chinese hamster ovary (CHO) cells |
| 350 | Desmond R. Harrell Stewart | Ph.D. | 2020 | Geoffrey J. Clark, Ph.D. | A novel role for RASSF1A in the regulation of RAS activation |
| 349 | Shuhan (Ellen) Meng | Ph.D. | 2020 | Chi Li, Ph.D. | Exosomes from embryonic stem cells as a prophylactic vaccine against lung cancer |
| 348 | Jordan B. Lynch | Ph.D. | 2020 | Daniel J. Conklin, Ph.D. | Tobacco product-derived aldehydes: Effects on circulating angiogenic cells & implications for cardiovascular disease |
| 347 | Fengyuan (Linda) Li | Ph.D. | 2020 | Wenke Feng, Ph.D. | Dual role of antimicrobial peptide cathelicidin in alcohol-associated liver disease |
| 346 | Lexiao (Monica) Jin | Ph.D. | 2020 | Daniel J. Conklin, Ph.D. | The cardiovascular effects of tobacco product-derived aldehydes: Contribution of Transient Receptor Potential Ankyrin-1 |
| 345 | Yuxuan Zheng | Ph.D. | 2020 | Walter H. Watson, Ph.D. | The role of Slc7a11 in controlling extracellular and intracellular redox environments of lung fibroblasts - potential targets for intervention in aging and idiopathic pulmonary fibrosis |
| 344 | Yihong (Summer) Li | Ph.D. | 2020 | Shao-yu Chen, Ph.D. | Sulphorophane protects against ethanol-induced apoptosis and teratogenesis through epigenetic modulation of anti-apoptotic genes |
| 343 | Andre D. Richardson | M.S. | 2020 | Daniel J. Conklin, Ph.D. | Tobacco-derived aldehydes: Platelet activation, thrombosis and the role of TRPA1 |
| 342 | Adrienne Bushau-Sprinkle | Ph.D. | 2020 | Eleanor Lederer, M.D. | Mechanistic insight of the role of NHERF1 in cisplatin-induced acute kidney injury |
| 341 | Al Hassan Kyakulaga | Ph.D. | 2019 | Ramesh C. Gupta, Ph.D. | Therapeutic potential of Withaferin A against non-small cell lung cancer |
| 340 | Joshua M. Royal | Ph.D. | 2019 | Nobuyuki Matoba, Ph.D. | A recombinant cholera toxin B subunit variant with a endoplasmic retention KDEL motif (CTB-KDEL) exhibits unique colon mucosal healing effects that have therapeutic implications for inflammatory bowel disease |
| 339 | Kevin M. Tyo | Ph.D. | 2019 | Jill Steinbach-Rankins, Ph.D. | Electrospun fibers and nanoparticles for the prevention of sexually transmitted infections |
| 338 | Sarah H. Shrader | M.S. | 2019 | Zhao-Hui (Joe) Song, Ph.D. | Discovery of novel molecular targets for endogenous and phytocannabinoids |
| 337 | Sophia M. Sears | M.S. | 2019 | Leah J. Siskind, Ph.D. | Characterizing the roles of neutral ceramidase in cisplatin-induced kidney injury |
| 336 | Aditya S. Barve | Ph.D. | 2019 | Levi Beverly, Ph.D. | Characterization of a more clinically relevant human leukemia xenograft model to examine perturbation of MET/SAM metabolism as a novel paradigm for MLL-R leukemia in vivo |
| 335 | Douglas J. O. Saforo | Ph.D. | 2019 | Levi Beverly, Ph.D. & Leah J. Siskind, Ph.D. | Characterizing the role of extracellular matrix in non-small cell lung carcinoma metastasis using a 3D microenvironment mimetic in-vitro culture system
|
| 334 | Christine E. Dolin | Ph.D. | 2019 | Gavin E. Arteel, Ph.D. & Michael L. Merchant, Ph.D. | Novel mechanisms and biomarkers in alcohol-induced organ injury |
| 333 | Mohamed Y. Mahmoud | Ph.D | 2019 | Jill M. Steinbach-Rankins, Ph.D. & Donald R. Demuth, Ph.D. | Development of BAR-peptide nanoparticles and electrospun fbers for the prevention and treatment of oral biofilms |
| 332 | Matthew W. Dent | M.S. | 2019 | Nobuyuki Matoba, Ph.D. | Development of a lectin-FC fusion protein with antiviral and anti-cancer activity |
| 331 | Aaron G. Whitt | M.S. | 2019 | Chi Li, Ph.D. | Paraoxonase 2 is critical for non-small cell lung carcinoma proliferation |
| 330 | Shanice V. Hudson | Ph.D. | 2018 | Gavin E. Arteel, Ph.D. & Hermann B. Frieboes, Ph.D. | Innate immunity, the extracellular matrix, and liver injury: mathematical modeling of metastatic potential and tumor development in alcoholic liver disease |
| 329 | Fengyuan (Linda) Li | M.S. | 2018 | Wenke Feng, Ph.D. | The role of cathelicidin in the regulation of gut microbiota and inflammasome activation in alcoholic liver disease |
| 328 | Jamie S. Rush | M.S. | 2018 | Brian P. Ceresa, Ph.D. | Epidermal growth factor-like ligands regulate dimer selection |
| 327 | Liya (Leah) Chen | Ph.D. | 2018 | Juliane I. Beier, Ph.D. | The role of aldehyde dehydrogenase 2 in liver injury caused by vinyl chloride and high-fat diet |
| 326 | Ashley M. Mudd | Ph.D. | 2018 | Ramesh C. Gupta, Ph.D. | Influence of bilberry-derived anthocyanidins on key regulators of colorectal cancer development |
| 325 | Christine Kim | M.S. | 2018 | Brian P. Ceresa, Ph.D. | Assessing the role of arsenite in disrupting the EGFR signaling axis |
| 324 | Qian (Zoe) Lin | Ph.D. | 2018 | Yi Tan, M.D., Ph.D. | A novel fibroblast growth factor 1 variant reverses nonalcoholic fatty liver disease in type 2 diabetes |
| 323 | Harshulkumar M. Pandit | Ph.D. | 2018 | Robert C.G. Martin II, M.D., Ph.D. | WNT/β-catenin mediated cancer stem cell activation in hepatocellular carcinoma |
| 322 | Jennifer H. Toyoda | M.S. | 2018 | John P. Wise, Sr., Ph.D. | Particulate hexavalent chromium does not induce centrosome amplification in sperm whale and bowhead whale cells |
| 321 | Samantha M. Carlisle | Ph.D. | 2018 | David W. Hein, Ph.D. | Deciphering the role of human arylamine N-acetyltransferase 1 in breast cancer cell metabolism using a systems biology approach |
| 320 | Hunter A. Miller | M.S. | 2018 | Hermann B. Frieboes, Ph.D. | Evaluation of nanoparticle transport and effect in heterogeneously vascularized tumor tissue |
| 319 | Nagawa El-Baz | M.S. | 2018 | Martin G. O'Toole, Ph.D. | A cancer targeted gold nanoparticles based MRI contrast agent |
| 318 | Ryan C. McAllister | Ph.D. | 2018 | Jessie Roman, M.D. | Perinatal nicotine with or without early life influenza infection leads to lung dysfunction with age |
| 317 | Julie A. Gosney | Ph.D. | 2018 | Brian P. Ceresa, Ph.D. | EGFR signaling from the early endosome |
| 316 | Cierra N. Sharp | Ph.D. | 2018 | Leah J. Siskind, Ph.D. | A clinically relevant mouse model of cisplatin-induced kidney injury |
| 315 | Alyssa S. Laun | M.S. | 2018 | Zhao-Hui (Joe) Song, Ph.D. | A study of GPR3, GPR6, and GPR12 as novel molecular targets for cannabidiol |
| 314 | Hongxue Shi | Ph.D. | 2018 | Matthew C. Cave, M.D. | The effects of polychlorinated biphenyls exposure on non-alcoholic fatty liver disease: Role of aryl hydrocarbon receptor |
| 313 | Anna L. Lang | Ph.D. | 2018 | Juliane I. Beier, Ph.D. | Vinyl chloride enhances diet-induced liver injury via metabolic dyshomeostasis: Critical role of mitochondria |
| 312 | Joshua M. Royal | M.S. | 2018 | Nobuyuki Matoba, Ph.D. | Therapeutic potential of a plant-made cholera toxin B subunit variant for the treatment of ulcerative colitis |
| 311 | Adrienne M. Bushau-Sprinkle | M.S. | 2018 | Eleanor Lederer, M.D. | Loss of the Na+ H- exchange regulatory Factor 1 results in increased susceptibility to cisplatin-induced acute kidney injury |
| 310 | Jamie L. Young | M.S. | 2018 | Gavin E. Arteel, Ph.D. | A model to study the effects of whole life chronic exposure to arsenic or cadmium on the development of adult metabolic syndrome: Initial characterization of hepatic changes |
| 309 | Marc M. Dwenger | M.S. | 2018 | Bradley B. Keller, M.D. | Maturation of human induced pluripotent stem cell derived engineered cardiac tissues using channel rhodopsin transfection and chronic optical pacing |
| 308 | J. Caleb Greenwell | Ph.D. | 2017 | Jessie Roman, M.D. | Age-related host factors regulate lung cancer progression |
| 307 | Marcus W. Stepp | Ph.D. | 2017 | David W. Hein, Ph.D. | Role of human arylamine N-acetyltransferase 1 in tumorigenesis and cancer biology |
| 306 | Lauren G. Poole-Hardy | Ph.D. | 2017 | Gavin E. Arteel, Ph.D. | Novel insight into the liver-lung axis in alcohol-enhanced acute lung injury |
| 305 | Zimple D Kurlawala | Ph.D. | 2017 | Levi J. Beverly, Ph.D. | UBQLN1: A multi-domain protein with multiple functions |
| 304 | Tuo Shao | Ph.D. | 2017 | Wenke Feng, Ph.D. | The role of HIF-1α in intestinal epithelial barrier function in alcoholic liver disease |
| 303 | Laila Al-Eryani | Ph.D. | 2017 | J. Christopher States, Ph.D. | miRNA expression changes in arsenic-induced skin cancer in vitro and in vivo |
| 302 | J. Mason Hoffman | M.S. | 2017 | J. Christopher States, Ph.D. | Targeting the major regulator of mitosis |
| 301 | Ashley M. Mudd | M.S. | 2017 | Ramesh C. Gupta, Ph.D. | Prevention and treatment of familial adenomatous polyposis and colorectal cancer by bilberry-derived anthocyanidins |
| 300 | Divya Karukonda | M.S. | 2017 | Ramesh C. Gupta, Ph.D. | Advances in tumor-targeted therapy using nanomedicine |
| 299 | Rachel M. Speer | M.S. | 2017 | John P. Wise, Sr., Ph.D. | The comparative cytotoxicity and genotoxicity of hexavalent chromium in humans and sea turtles |
| 298 | Tess V. Dupre | Ph.D. | 2017 | Leah J. Siskind, Ph.D. | Sphingolipids in models of kidney injury and disease |
| 297 | Elizabeth M. Hollis | M.S. | 2017 | Ayman El-Baz, Ph.D. | Diffusion-weighted magnetic resonance imaging in diagnosing graft dysfunction: a non-invasive alternative to renal biopsies |
| 296 | Al Hassan Kyakulaga | M.S. | 2017 | Ramesh C. Gupta, Ph.D. | Withaferin A synergistically enhances the effect of paclitaxel against lung cancer |
| 295 | Stephan L. Wechman | Ph.D. | 2017 | Kelly M. McMasters, M.D., Ph.D. | Characterization of a mutant oncolytic adenovirus and the role of JNK in enhancing virotherapy |
| 294 | Nicole M. Jackson-Santerre | Ph.D. | 2017 | Brian P. Ceresa, Ph.D. | Identifying the signaling mechanisms of EGFR-mediated apoptosis |
| 293 | Jaspreet S. Grewal | Ph.D. | 2017 | Jason A. Chesney, M.D., Ph.D. | Targeting the glucose metabolism of myeloid-derived suppressor cells (MDSCs) to stimulate cancer immunity |
| 292 | Christine E. Dolin | M.S. | 2017 | Juliane I. Beier, Ph.D. | The effects of moderate alcohol consumption and inflammation on the hepatic matrisome and the renal cortex proteome |
| 291 | Christopher P. Shidal | Ph.D. | 2017 | Keith R. Davis, Ph.D. | Combating malignant melanoma with the multifaceted soy-derived peptide lunasin |
| 290 | Aaron M. Neely | Ph.D. | 2017 | Chi Li, Ph.D. | The interaction of homoserine lactones and paraoxonase 2 modulates cell death signaling and cell proliferation |
| 289 | Gretchen E. Holz | M.S. | 2016 | Igor S. Lukashevich, M.D., Ph.D., D.Sc. | Proinflammatory cytokines promote viral replication and cell cycle mediators in arenavirus-induced hepatitis |
| 288 | Glenn W. Vicary | Ph.D. | 2016 | Jesse Roman, M.D. | The role of nicotine, α7 nicotinic acetylcholine receptors and extracellular matrix remodeling in pulmonary fibrosis |
| 287 | Aditya S. Barve | M.S. | 2016 | Levi J. Beverly, Ph.D. | Establishing a clinically relevant mouse model of human AML to test novel transmethylation inhibitors |
| 286 | Kevin M. Tyo | M.S. | 2016 | Jill Steinbach-Rankins, Ph.D. | Multipurpose tenofovir disoproxil fumarate electrospun fibers for the prevention of HIV-1 and HSV-2 infections |
| 285 | Justin L. Hallgren | Ph.D. | 2016 | Michal Hetman, M.D., Ph.D. | The role of the nucleolus in neurodegeneration |
| 284 | Anna L. Lang | M.S. | 2016 | Juliane I. Beier, Ph.D. | Vinyl chloride-diet interactions in liver disease: potential roles of autophagy and energy management |
| 283 | Wei-Yang (Jeremy) Chen | Ph.D. | 2016 | Swati Joshi-Barve, Ph.D. & Craig McClain, M.D. | Acrolein is a critical mediator of alcohol-induced liver and intestinal injury in alcoholic liver disease |
| 282 | Jordan B. Finch | M.S. | 2016 | Daniel J. Conklin, Ph.D. | Air pollution, pulmonary oxidative stress, and the endothelin system in the development of cardiovascular injury |
| 281 | Julie A. Gosney | M.S. | 2016 | Brian P. Ceresa, Ph.D. | Isolation of EGFR-containing early endosomes |
| 280 | Cierra N. Sharp | M.S. | 2016 | Leah J. Siskind, Ph.D. | Developing a more clinically-relevant mouse model of cisplatin-induced nephrotoxicity |
| 279 | Dominique Z. Jones | Ph.D. | 2016 | La Creis R. Kidd, Ph.D. & Geoffrey J. Clark, Ph.D. | MicroRNA-186 and metastatic prostate cancer |
| 278 | Diana V. Avila | Ph.D. | 2016 | Shirish Barve, Ph.D. & Leila Gobejishvili, Ph.D. | Role of phosphodiesterase-4 in alcohol-induced organ injury |
| 277 | Aaron M. Neely | M.S. | 2016 | Chi Li, Ph.D. | Modulation of cell death signaling and cell proliferation by the interaction of homoserine lactones and paraoxonase 2 |
| 276 | Hridgandh Donde | Ph.D. | 2015 | Shirish Barve, Ph.D. | Mechanisms and intervention strategies for alcohol and HIV-antiretroviral therapy-induced liver injury |
| 275 | Keegan J. Baldauf | Ph.D. | 2015 | Nobuyuki Matoba, Ph.D. | Studies on the impacts of a plant-made recombinant cholera toxin B subunit on the gastrointestinal tract |
| 274 | Pritesh P. Kumar | Ph.D. | 2015 | Zhao-Hui (Joe) Song, Ph.D. | Searching for novel ligands for the cannabinoid and related receptors |
| 273 | Zimple D. Kurlawala | M.S. | 2015 | Levi J. Beverly, Ph.D. | Regulation of receptor tyrosine kinases by UBQLN1 |
| 272 | Stephen L. Wechman | M.S. | 2015 | Kelly M. McMasters, M.D., Ph.D. | Improved oncolytic virotherapy by increasing virus spread within tumors |
| 271 | Lauren G. Poole | M.S. | 2015 | Gavin E. Arteel, Ph.D. | Alcohol-enhanced acute lung injury: Role of plasminogen activator inhibitor-1 and the transitional extracellular matrix |
| 270 | Harshulkumar M. Pandit | M.S. | 2015 | Robert C.G. Martin II, M.D., Ph.D. | Identifying hepatocellular carcinoma (HCC) cells with cancer stem cell-like properties |
| 269 | Nicole M. Jackson | M.S. | 2015 | Brian P. Ceresa, Ph.D. | The regulation and mechanisms of EGFR-mediated apoptosis in MDA-MB-468 cells |
| 268 | Tess V. Dupre | M.S. | 2015 | Leah J. Siskind, Ph.D. | Identifying novel renoprotective strategies for cisplatin-induced AKI |
| 267 | Samantha M. Carlisle | M.S. | 2015 | David W. Hein, Ph.D. | Investigating pathway changes associated with varying levels of human arylamine N-acetyltransferase 1 (NAT1) activity |
| 266 | Tareq Al-Maqtari | Ph.D. | 2015 | Aruni Bhatnagar, Ph.D. & Kyung Hong, Ph.D. | Promoting differentiation and survival of human c-kit+ cardiac progenitor cells ex vivo |
| 265 | J. Caleb Greenwell | M.S. | 2015 | Jesse Roman, M.D. | Role of nicotinic acetylcholine receptors in lung cancer |
| 264 | Veronica L. Massey | Ph.D. | 2014 | Gavin E. Arteel, Ph.D. | Extracellular matrix proteins and the liver-lung axis in disease |
| 263 | Christopher G. England | Ph.D. | 2014 | Hermann B. Frieboes, Ph.D. | Study of novel nanoparticle transport and drug release for cancer treatment |
| 262 | Banrida Wahlang | Ph.D. | 2014 | Matthew C. Cave, M.D. | Evaluating the effects of polychlorinated biphenyls in non-alcoholic fatty liver disease |
| 261 | Christopher P. Shidal | M.S. | 2014 | Keith R. Davis, Ph.D. | Lunasin reduces the melanoma stem cell population in-vitro and inhibits tumor proliferation in-vivo |
| 260 | Dominique Z. Jones | M.S. | 2014 | La Creis R. Kidd, Ph.D. | The role of inflammatory and immune response-related sequence variants and miR-186 in prostate cancer |
| 259 | Diana V. Avila | M.S. | 2014 | Shirish Barve, Ph.D. & Leila Gobejishvili, Ph.D. | Pathogenic role of PDE4 in the development of alcohol induced hepatic steatosis |
| 258 | Wei-Yang (Jeremy) Chen | M.S. | 2014 | Craig J. McClain, M.D. | The pathogenic role of acrolein in alcoholic liver disease |
| 257 | Marcus W. Stepp | M.S. | 2014 | David W. Hein, Ph.D. | Inducible tumor difference between rapid and slow rat Nat2 congenic Fischer 344 rats administered methyl-nitrosourea |
| 256 | Morgan L. Stathem | M.S. | 2014 | Levi J. Beverly, Ph.D. & Leah J. Siskind, Ph.D. | Building a metabolic bridge between glycolysis and sphingolipid biosynthesis: Implications for cancer |
| 255 | Christopher L. Barton | Ph.D. | 2014 | Kenneth E. Palmer, Ph.D. | Evaluation of the safety and pharmacokinetic profile of the broad spectrum antiviral lectin griffithsin |
| 254 | Ryan C. McAllister | M.S. | 2014 | Colleen B. Jonsson, Ph.D. | Development of models for the study of the molecular mechanisms of host restriction and adaptation of hantaviruses |
| 253 | Zachary J. Pritchard | M.S. | 2014 | Uma Sankar, Ph.D. | Bone strength and architecture: pharmacological targeting of CaMKK2 as a method for enhancing bone quality |
| 252 | Laila Al-Eryani | M.S. | 2014 | Matthew C. Cave, M.D. | The role of pesticides in non-alcoholic fatty liver disease (NAFLD) |
| 251 | Melissa E. Skibba | M.S. | 2014 | Lu Cai, M.D., Ph.D. | Preventive effect of non-mitogenic acidic fibroblast growth factor on diabetes-induced testicular cell death |
| 250 | Justin L. Hallgren | M.S. | 2014 | Michal Hetman, M.D., Ph.D. | The role of the nucleolus in neurodegeneration |
| 249 | Pei-Hsin (Penny) Cheng | Ph.D. | 2013 | Kelly M. McMasters, M.D., Ph.D. | Cyclin E induction and oncolytic replication of E1B-deleted adenoviruses |
| 248 | Amanda B. Lasnik | M.S. | 2013 | Kenneth E. Palmer, Ph.D. | Preclinical safety assessment of griffithsin-based vaginal microbicides |
| 247 | Alex C. Belshoff | Ph.D. | 2013 | Teresa Fan, Ph.D. | Probing the anti-cancer mechanism of selenite: a metabolic approach |
| 246 | Robin H. Schmidt | Ph.D. | 2013 | Gavin E. Arteel, Ph.D. | Olanzapine-induced liver injury: Direct metabolic effects, exacerbation by high-fat diet, and protection with sulforaphane |
| 245 | Christopher G. England | M.S. | 2013 | Hermann B. Frieboes, Ph.D. | Optimization of drug uptake into solid tumors using an integrated experimental/computational modeling approach |
| 244 | Glenn W. Vicary | M.S. | 2013 | Jesse Roman, M.D. | The role of α7 nicotinic acetylcholine receptors in lung injury and repair |
| 243 | Hridgandh Donde | M.S. | 2013 | Shirish Barve, Ph.D. | Role of ethanol as a cofactor in HAART induced hepatic steatosis and injury |
| 242 | Veronica L. Massey | M.S. | 2012 | Gavin E. Arteel, Ph.D. | Integrin inhibitor cyclorgdfv blunts enhanced LPS-induced liver injury caused by ethanol in mice |
| 241 | Keegan J. Baldauf | M.S. | 2012 | Gavin E. Arteel, Ph.D. | Acetaldehyde dehydrogenase 2 (ALDH2) activation protects hepatocytes from mitochondrial damage and death caused by 4-hydroxynonenal |
| 240 | Madhuvanti Patil | Ph.D. | 2012 | Shirish Barve, Ph.D. | The role of the transmethylation pathway in the regulation of cell death in leukemic CD4+ T cells |
| 239 | Colins O. Eno | Ph.D. | 2012 | Chi Li, Ph.D. | The role of endogenous Bcl-xL in regulation of apoptotic signaling pathways |
| 238 | Akshata Moghe | Ph.D. | 2012 | Shirish Barve, Ph.D. | Role of chromatin remodeling in curcumin-mediated regulation of gene expression in hepatocellular carcinoma |
| 237 | Carmine S. Leggett | Ph.D. | 2012 | David W. Hein, Ph.D. | Role of human arylamine N-acetyltransferase in carcinogen metabolism and human breast cancer progression |
| 236 | Daniel Fioret | M.S. | 2012 | Jesse Roman, M.D. | Idiopathic pulmonary fibrosis: Diagnosis, management, and the search for a cure |
| 235 | Tareq Al-Maqtari | M.S. | 2012 | Uma Sankar, Ph.D. | Approaches in the treatment of Parkinson's disease: A focus on stem cell-based therapies |
| 234 | Banrida Wahlang | M.S. | 2012 | Matthew Cave, M.D. | Polychlorinated biphenyl 153 exacerbates nonalcoholic fatty liver disease in C57BL/6 mice |
| 233 | Huihui Wu | M.S. | 2012 | Al Cunningham, Ph.D. | Structure-activity relationship model for estrogen receptor ligands |
| 232 | Elaina Marie Chambers | Ph.D. | 2012 | Shirish Barve, Ph.D. | The role of phosphodiesterase 4 in diabetic inflammation |
| 231 | Pritesh P. Kumar | M.S. | 2011 | Zhao-Hui (Joe) Song, Ph.D. | Searching for novel ligands for cannabinoid and related receptors |
| 230 | Benjamin M. Risner | M.S. | 2011 | Richard Goldstein, M.D., Ph.D. | Pharmacists as mid-level healthcare providers and the clinical results of a pharmacist-led diabetes disease management program |
| 229 | Stephanie A. Mathews | Ph.D. | 2011 | Shirish Barve, Ph.D. | Role of HDACs and SAM in interferon-alpha signaling and epigenetic regulation of anti-HCV gene expression |
| 228 | Erica N. Rogers | Ph.D. | 2011 | J. Christopher States, Ph.D. | The role of curcumin in response to BPDE-induced DNA damage in human lung epithelial cells |
| 227 | Katherine S. Bourcy | Ph.D. | 2011 | Y. James Kang, Ph.D. | Mechanistic insights into copper-induced regression of heart hypertrophy |
| 226 | Ntube Nini Olive Ngalame | Ph.D. | 2011 | J. Christopher States, Ph.D. | Arsenic-induced developmental changes in the liver and adult cardiovascular disease |
| 225 | Shelia A. Arnold | Ph.D. | 2011 | Theo Hagg, M.D., Ph.D. | Roles of 5HT1A receptor in CNS neurogenesis and ADAM21 in spinal cord injury |
| 224 | Clarisse S. Muenyi | Ph.D. | 2011 | J. Christopher States, Ph.D. | Mitigating cisplatin resistance in ovarian cancer |
| 223 | Lori M. Millner | Ph.D. | 2011 | David W. Hein, Ph.D. | Functional analysis of N-acetyltransferase (NAT1*14B and NAT1*10) in complete NATb and NATa mRNA |
| 222 | Pei-Hsin (Penny) Cheng | M.S. | 2011 | Kelly M. McMasters, M.D., Ph.D. | Adenovirus-induced cyclin E activates CDK2 for virus replication |
| 221 | Lindsey Jay Stallons | Ph.D. | 2011 | J. Christopher States, Ph.D. | DNA polymerase iota promotes G2/M checkpoint activation and genetic stability after UV-induced DNA damage |
| 220 | Shyam Sunder Bansal | Ph.D. | 2011 | Ramesh C. Gupta, Ph.D. | Development and evaluation of polymeric implants of curcumin for enhanced chemopreventive activity |
| 219 | Christopher L. Barton | M.S. | 2011 | Kenneth E. Palmer, Ph.D. | Profile of systemic treatment with the antiviral lectin griffithsin in guinea pigs |
| 218 | Pengxiao Cao | Ph.D. | 2011 | Ramesh C. Gupta, Ph.D. | Prevention and treatment of lung cancer by green tea polyphenols |
| 217 | Gilandra K. Russell | Ph.D. | 2011 | Ramesh C. Gupta, Ph.D. | Sustained systemic delivery of chemopreventive agents in inhibiting dibenzo[a,l]pyrene-induced DNA adducts in the lungs of A/J mice |
| 216 | Jianxun Wang | Ph.D. | 2011 | Paul N. Epstein, Ph.D. | Cardiac abnormalities after transaortic constriction are worsened by changing glucose metabolism and benefited by repair of mitochondrial DNA |
| 215 | Robin H. Schmidt | M.S. | 2011 | Gavin E. Arteel, Ph.D. | Sulforaphane prevents acetaminophen-induced hepatic injury in mice |
| 214 | Nicole A. Lavender | Ph.D. | 2010 | La Creis R. Kidd, Ph.D. | The role of genetic and environmental oxidative stress factors in prostate cancer |
| 213 | Lu Yang | Ph.D. | 2010 | Paul N. Epstein, Ph.D. | Adriamycin nephrotoxicity is reduced by metallothionein over-expression and kidney gene expression is modified by diabetes in the OVE26 diabetic model |
| 212 | Afsoon Moktar | Ph.D. | 2010 | Ramesh C. Gupta, Ph.D. | Cigarette smoke, DNA damage and repair in human cervical and vaginal cells in vitro and ex vivo |
| 211 | Carmine S. Leggett | M.S. | 2010 | David W. Hein, Ph.D. | Effects of CYP1A2, NAT1, and NAT2 genetic variants in nucleotide excision repair-deficient human fibroblasts: Implications for toxicological risk from environmental arylamines |
| 210 | Matthew R. Zajack | M.S. | 2010 | J. Christopher States, Ph.D. | Arsenic in drinking water causes gene expression changes in the liver related to inflammation and metabolic dysfunction and accelerates atherosclerosis in APOE-/- mice |
| 209 | Akshata Moghe | M.S. | 2010 | Shirish Barve, Ph.D. | Curcumin reactivates epigenetically silenced tumor suppressor gene tissue factor pathway inhibitor-2 in hepatocellular carcinoma cells |
| 208 | Madhuvanti Patil | M.S. | 2010 | Shirish Barve, Ph.D. | Role of the transmethylation pathway in the regulation of cell death in T leukemic cells |
| 207 | Colins O. Eno | M.S. | 2010 | Chi Li, Ph.D. | Mechanism of regulation of apoptosis by the BCL-2 proteins BCL-XL and BCL-XS |
| 206 | Christelle K. Kamga | Ph.D. | 2010 | Yang Wang, M.D., Ph.D. | GSH transport through the dicarboxylate carrier: A key component in UCP4-mediated antioxidants effects in neuronal-like PC12 cells |
| 205 | John Philipose | Ph.D. | 2010 | Michele Pisano, Ph.D. | Craniofacial anomalies: sensitivity of the neural crest to altered folate metabolism |
| 204 | Aisha Isabelle Bagshaw | M.S. | 2010 | Aruni Bhatnagar, Ph.D. | Potential cardiotoxic impact of aldehydes in the progression of atherosclerosis |
| 203 | LaSharon D. Mosley | Ph.D. | 2009 | James W. Lillard, Jr., Ph.D. | Mechanisms mediated by CXCL12 signaling through CXCR4 and CXCR7 in breast cancer |
| 202 | J. Phillip Kaiser | Ph.D. | 2009 | Gavin E. Arteel, Ph.D. | The role of PKC-epsilon in models of alcohol- and toxin-induced liver disease |
| 201 | Ntube Nini Olive Ngalame | M.S. | 2009 | J. Christopher States, Ph.D. | Arsenic-induced developmental changes in the liver and adult cardiovascular disease |
| 200 | Pengxiao Cao | M.S. | 2009 | Ramesh C. Gupta, Ph.D. | Effect of green tea catehins and hydrolyzable tannins on benzo[a]pyrene-induced DNA adducts and structure activity relationship |
| 199 | Shyam Sunder Bansal | M.S. | 2009 | Ramesh C. Gupta, Ph.D. | A novel implantable drug delivery system of curcumin for cancer chemoprevention |
| 198 | Jean-Claude Nzimulinda | Ph.D. | 2009 | Zhao-Hui (Joe) Song, Ph.D. | Ligand binding, activation, and dimerization of CB2 cannabinoid receptor |
| 197 | Yang Zhou | Ph.D. | 2008 | Y. James Kang, Ph.D. | Copper-induced regression of cardiomyocyte hypertrophy through alteration of VEGF/VEGFR pathways |
| 196 | Nason P. Schooler | M.S. | 2008 | John W. Eaton, Ph.D. | The use of the reducing agent N-(2-mercaptopropionyl)glycine to detoxify oxidized lipids in atherosclerotic lesions |
| 195 | Katharine Shumate Richardson | Ph.D. | 2008 | Wayne Zundel, Ph.D. | Regulation of placental ribonuclease inhibitor by tumor suppressor Von Hippel-Lindau |
| 194 | Stephanie A. Mathews | M.S. | 2008 | Shirish Barve, Ph.D. | Impaired SAM metabolism and IFNα antiviral signaling: Relevance to hepatitis C virus |
| 193 | Robert C.G. Martin, II | Ph.D. | 2008 | David W. Hein, Ph.D. | Polymorphisms in manganese superoxide dismutase as a risk factor for cancer |
| 192 | Nicole A. Lavender | M.S. | 2008 | La Creis R. Kidd, Ph.D. | Joint modifying effects of variant oxidative stress factors in relation to prostate cancer |
| 191 | Emily Roberts Esposito | Ph.D. | 2008 | Michele Pisano, Ph.D. | In vivo and in vitro models for cigarette smoke-induced low birth weight and other adverse developmental outcomes |
| 190 | Christina Blume Clark | Ph.D. | 2008 | Evelyne Gozal, Ph.D. | The role of HSP90 in PC-12 cell survival |
| 189 | Elaina Marie Chambers | M.S. | 2008 | Shirish Barve, Ph.D. | Immune dysregulation and diabetes: A potential role of phosphodiesterases |
| 188 | Thomas J. Schlierf | M.S. | 2008 | David W. Hein, Ph.D. | Role of N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in breast cancer risk with exposure to aromatic and heterocyclic amine carcinogens |
| 187 | Katherine S. Bourcy | M.S. | 2008 | Y. James Kang, Ph.D. | The role of vascular endothelial growth factor receptors in copper-induced regression of cardiac hypertrophy |
| 186 | Carl Alexander Carrasquer | Ph.D. | 2008 | Zhao-Hui (Joe) Song, Ph.D. | Activation and regulation of cannabinoid receptors |
| 185 | Clarisse S, Muenyi | M.S. | 2008 | J. Christopher States, Ph.D. | Improving the efficacy of platinum chemotherapy against ovarian cancer |
| 184 | Lindsey Jay Stallons | M.S. | 2008 | W. Glenn McGregor, M.D. | Mutagenic and tumor suppressor functions of DNA polymerase iota in mammalian cells |
| 183 | Lori M. Millner | M.S. | 2008 | David W. Hein, Ph.D. | Effect of N-acetyltransferase (NAT1) polymorphism on mutagenesis and DNA adduct formation |
| 182 | Shankang Ma | M.S. | 2008 | Y. James Kang, Ph.D. | Metallothionein gene therapy for chemically-induced liver fibrosis |
| 181 | Jean-Claude Nzimulinda | M.S. | 2008 | Zhao-Hui (Joe) Song, Ph.D. | Residues accessible in the binding site crevice of transmembrane helix 2 of CB2 cannabinoid receptor |
| 180 | Erica N. Rogers | M.S. | 2008 | J. Christopher States, Ph.D. | The modulation of DNA damage by curcumin |
| 179 | Nicholas B. Watson | Ph.D. | 2008 | W. Glenn McGregor, M.D. | RAD18 is recruited to stalled DNA replication forks and is required for recruitment of accessory translesion synthesis proteins |
| 178 | Xiaoyan (Susan) Zhang | Ph.D. | 2008 | David W. Hein, Ph.D. | Characterization of N-acetyltransferase 1 (NAT1) expression in breast cancer |
| 177 | Ya Fatou Njie | Ph.D. | 2007 | Zhao-Hui (Joe) Song, Ph.D. | Cannabinoids as potential therapeutic agents for glaucoma |
| 176 | Christelle K. Kamga | M.S. | 2007 | Yang Wang, M.D., Ph.D. | UCP4 is a key regulator of mitochondrial antioxidant defense in rat PC12 cells |
| 175 | Jianxun Wang | M.S. | 2007 | Paul N. Epstein, Ph.D. | The changes of fructos-2,6-biphosphate level in transgenic mice causing cardiomyopathy |
| 174 | Joshua M. Thornburg | Ph.D. | 2007 | Jason A. Chesney, M.D., Ph.D. | Identification of aspartate aminotransferase as a novel target for anti-neoplastic research |
| 173 | Samuel C. McNeely | Ph.D. | 2007 | J. Christopher States, Ph.D. | Sensitivity to sodium arsenite depends upon susceptibility to mitotic arrest-associated apoptosis |
| 172 | Jason M. Walraven | Ph.D. | 2007 | David W. Hein, Ph.D. | Computational and functional analyses of human and rat N-acetyltransferase genetic variants N-acetyltransferase genetic variants |
| 171 | J. Phillip Kaiser | M.S. | 2007 | Gavin E. Arteel, Ph.D. | The role of PKC-epsilon in alcoholic liver disease |
| 170 | Agata M. Habas | Ph.D. | 2007 | Michal Hetman, M.D., Ph.D. | The role of GSK3β and NFATc4 in NMDA-mediated neuronal survival |
| 169 | B. Frazier Taylor | Ph.D. | 2007 | J. Christopher States, Ph.D. | Arsenite inhibition of mitotic progression |
| 168 | LaSharon D. Mosley | M.S. | 2007 | Richard E. Goldstein, M.D., Ph.D. | Estrogen receptors in thyroid cell proliferation |
| 167 | Lu Yang | M.S. | 2007 | Paul N. Epstein, Ph.D. | Protection by metallothionein from adriamycin induced nephropathy in mice and gene expression profiling during progression of diabetic nephropathy |
| 166 | Chad A. Dumstorf | Ph.D. | 2007 | W. Glenn McGregor, M.D. | Participation of mouse DNA polymerases iota, eta, and rev1 in translesion synthesis of carcinogen induced DNA adducts and carcinogenesis |
| 165 | Kristin J. Metry | Ph.D. | 2007 | David W. Hein, Ph.D. | Role of N-acetyltransferase 2 polymorphism in DNA adduct formation and mutagenesis by aromatic and heterocyclic amine carcinogens |
| 164 | Jin Liu | Ph.D. | 2007 | Michael E. Brier, Ph.D. | Design evaluation for pharmacokinetic studies in patients with renal impairment |
| 163 | Kevyn E. Merten | Ph.D. | 2007 | Y. James Kang, Ph.D. | Effect of zinc on doxorubicin-induced activation of the calcineurin signaling pathway and the relation to myocardial cell death and hypertrophy |
| 162 | Alex Carrasquer | M.S. | 2006 | Zhao-Hui (Joe) Song, Ph.D. | The effects of polymorphisms on the function of the CB2 cannabinoid receptor |
| 161 | Afsoon Moktar | M.S. | 2006 | Ramesh C. Gupta, Ph.D. | Cigarette smoking as a major cofactor in human cervical cancer |
| 160 | Emily Roberts Esposito | M.S. | 2006 | M. Michele Pisano, Ph.D. | Low birth weight-Consequences of maternal tobacco smoke exposure during embryonic and fetal development |
| 159 | Nstang Miranda Nebane | Ph.D. | 2006 | Zhao-Hui (Joe) Song, Ph.D. | Structure-activity relationship of the CB1 and CB2 cannabinoid receptors |
| 158 | Yang Zhou | M.S. | 2006 | Y. James Kang, Ph.D. | Copper inhibition of hydrogen peroxide-induced hypertrophy in H9C2 embryonic rat cardiac cells |
| 157 | Xiaoqiang (Steven) Xu | M.S. | 2006 | Theresa Whei-Mei Fan, Ph.D. | TrxR SECIS RNA synthesis and biophysical characterization |
| 156 | Rundong (Ray) Zhang | Ph.D. | 2006 | Zhao-Hui (Joe) Song, Ph.D. | Structure and function of CB2 cannabinoid receptors |
| 155 | Sheila A. Mullins | M.S. | 2006 | Paul N. Epstein, Ph.D. | Effects of fructose-2,6-bisphosphate on Akt phosporylation and insulin signaling in cardiomyocytes |
| 154 | Joshua M. Thornburg | M.S. | 2006 | Jason A. Chesney, M.D., Ph.D. | Role of lactate dehydrogenase A (LDH-A) in oncogenic transformation; Revisiting a classic enzyme |
| 153 | Wei (Wendy) Yuan Chang | Ph.D. | 2006 | Theresa S. Chen, Ph.D. | Mechanism of 4-hydroxynonenal induced toxicity in Jurkat CD4+ T lymphocytes |
| 152 | Katharine S. Richardson | M.S. | 2006 | Wayne S. Zundel, Ph.D. | Impact of von Hippel-Lindau in regulating ribonuclease activity in renal cell carcinoma |
| 151 | Yu (Janet) Zang | Ph.D. | 2006 | David W. Hein, Ph.D. | Functional characterization and mechanistic studies on single nucleotide polymorphisms of human N-acetyltransferase 2 |
| 150 | Tanvi S. Jani | Ph.D. | 2006 | Shirish Barve, Ph.D. | Role of methionine adenosyltransferase II (MAT II) and S-adenosylmethionine (SAMe) in survival of CD4+ T lymphocytes: Relevance to immune dysfunction |
| 149 | Stephen R. Reeves | Ph.D. | 2006 | David Gozal, M.D. | Chronic intermittent hypoxia and respiratory plasticity |
| 148 | Paul C. Porter | Ph.D. | 2005 | J. Christopher States, Ph.D. | Discovery and functional analysis of XPA polymorphisms and use of telomerase immortalized cells for nucleotide excision repair studies |
| 147 | Ya Fatou Njie | M.S. | 2005 | Zhao-Hui (Joe) Song, Ph.D. | Effects of the endogenous cannabinoid, noladin ether on aqueous humor outflow facility mediated by the CB1 cannabinoid receptor |
| 146 | Molly Anne Davis | M.S. | 2005 | Gavin E. Arteel, Ph.D. | Characterization of recovery from liver damage by choline deficiency: Effect of biochemical modulators of lipid metabolism? |
| 145 | E. Cristian Campian | Ph.D. | 2005 | Frederick W. Benz, Ph.D. | Acute acrylonitrile toxicity: Mechanistic Studies |
| 144 | Anwar Husain | Ph.D. | 2005 | David W. Hein, Ph.D. | Regulatory control regions of human arylamine N-acetyltransferase 1 and 2: Implications for genetic predisposition to breast cancer |
| 143 | Xiaoyan (Susan) Zhang | M.S. | 2005 | David W. Hein, Ph.D. | Role of N-acetyltransferase (NAT) polymorphism on 4,4’-methylene bis (2-chloroaniline) and 4,4’-methylenedianiline (MDA) acetylation, MDA hepatotoxicity and a proposal to study NAT expression in breast cancer |
| 142 | Gilandra K. Russell | M.S. | 2005 | Gavin E. Arteel, Ph.D. | Protection of cultured hepatocytes from hypoxic death by ATP-delivery with lipid vesicles |
| 141 | Samuel C. McNeely | M.S. | 2005 | J. Christopher States, Ph.D. | Arsenic: A potential chemotherapeutic for melanoma |
| 140 | Tanvi S. Jani | M.S. | 2005 | Shirish Barve, Ph.D. | Methionine adenosyltransferase IIA (MAT IIA) and S-adenosylmethionine (SAMe) are critical for the survival of CD4+ T lymphocytes |
| 139 | Jin Liu | M.S. | 2005 | Michael E. Brier, Ph.D. | An evaluation of pharmacokinetic study design for describing drug disposition in renal failure |
| 138 | Kevyn E. Merten | M.S. | 2005 | Y. James Kang, Ph.D. | Molecular mechanisms of metallothionein protection from adriamycin cardiotoxicity |
| 137 | Jason M. Walraven | M.S. | 2005 | David W. Hein, Ph.D. | Investigations of N-acetyltransferases in human hepatocytes and rat models |
| 136 | Nicholas B. Watson | M.S. | 2005 | W. Glenn McGregor, M.D. | The ubiquitin ligase RAD18 is implicated in mutagenic translesion synthesis of DNA damage in human cells |
| 135 | Prachi T. Hote | M.S. | 2004 | Shirish Barve, Ph.D. | Ethanol mediated loss of MAT2A (methionine adenosylmethyltransferase) expression and SAMe (S-adenosylmethionine) biosynthesis induced FAS-mediated CD4+ T lymphocyte death: Potential mechanism(s) for alcohol mediated immunotoxicity |
| 134 | Ntsang Miranda Nebane | M.S. | 2004 | Zhao-Hui (Joe) Song, Ph.D. | Effects of D3.49N mutations on ligand binding and activation of the CB1 and CB2 cannabinoid receptors |
| 133 | Xia (Clare) Shen | Ph.D. | 2004 | Paul N. Epstein, Ph.D. | Mitochondrial damage and biogenesis in diabetic heart and protection by overexpression of manganese superoxide dismutase |
| 132 | Chad A. Dumstorf | M.S. | 2004 | W. Glenn McGregor, M.D. | Mutagenesis of induced tumors in murine lung |
| 131 | Yuanqi Zhu | Ph.D. | 2004 | David W. Hein, Ph.D. | Human NAT1 genetic polymorphisms: coding region & non-coding region |
| 130 | Agata M. Habas | M.S. | 2004 | Michal Hetman, M.D., Ph.D. | The role of nuclear factors of activated T-cells (NFAT) in neuronal death |
| 129 | Yu (Cindy) Wang | M.S. | 2004 | David Gozal, M.D. | Cooperative effects of amyloid beta (25-35) and hypoxia-reoxygenation on cell death in primary cultured mouse neurons of cerebral cortex |
| 128 | Christopher R. Cunningham | Ph.D. | 2004 | Steven R. Myers, Ph.D. | Hemoglobin adducts and the role of genotype in the modification of risk associated with tobacco smoke exposure to the fetus |
| 127 | Xiaoyan (Nina) Li | Ph.D. | 2004 | Paul N. Epstein, Ph.D. | The roles of pancreatic beta cell antioxidants in islet transplantation and type 1 diabetes |
| 126 | Kristin J. Metry | M.S. | 2004 | David W. Hein, Ph.D. | NAT polymorphism in breast cancer risk |
| 125 | Wei (Wendy) Yuan Chang | M.S. | 2004 | Theresa S. Chen, Ph.D. | Mechanism of oxidative stress induced cell toxicity |
| 124 | Jennifer A. Loehle | M.S. | 2004 | David W. Hein, Ph.D. | Pediatric pharmacogenetic studies: The advent of genomics, clinical implications and current initiatives in research |
| 123 | April K. Hartford | Ph.D. | 2004 | Nicholas A. Delamere, Ph.D. | NA,K-ATPase Alpha 2: Its role in calcium homeostasis, signaling and cell survival in astrocytes |
| 122 | Laila Elsherif | Ph.D. | 2004 | Y. James Kang, Ph.D. | Dietary copper restriction-induced cardiomyopathy and its reversibility in mice |
| 121 | Jian Li | Ph.D. | 2003 | John W. Eaton, Ph.D. | Oxygen toxicity and mitochondrial metabolism |
| 120 | Yu (Janet) Zang | M.S. | 2003 | David W. Hein, Ph.D. | Mechanistic studies on the T341C (Ile114Thr) single nucleotide polymorphism of human N-acetyltransferase 2 |
| 119 | Rundong (Ray) Zhang | M.S. | 2003 | Zhao-Hui (Joe) Song, Ph.D. | Cysteine 89(2.69) in the second transmembrane domain of human CB2 receptor is exposed in the ligand binding crevice |
| 118 | Hainan Chen | Ph.D. | 2003 | Paul N. Epstein, Ph.D. | Studies on the effects of pancreatic beta cell antioxidant transgenes on experimental models of diabetes |
| 117 | Terry L. Wright, Jr. | M.S. | 2003 | Gavin E. Arteel, Ph.D. | The TNFalpha paradox in ischemic heart disease |
| 116 | Denise R. Clark | M.S. | 2003 | W. Glenn McGregor, M.D. | Ribozyme-mediated REV1L inhibition reduces UV-induced mutations in the human HPRT gene |
| 115 | Paul C. Porter | M.S. | 2003 | J. Christopher States, Ph.D. | Detection and functional analysis of polymorphic XPA alleles |
| 114 | Jason C. Lambert | Ph.D. | 2003 | Y. James Kang, Ph.D. | Zinc inhibition of acute ethanol-induced liver injury |
| 113 | Yuanqi Zhu | M.S. | 2002 | David W. Hein, Ph.D. | Functional characterization of NAT gene polymorphisms |
| 112 | Xiaoyan (Nina) Li | M.S. | 2002 | Paul N. Epstein, Ph.D. | Metallotheionein overexpression prolongs grafts survival in the early phase of pancreatic islet transplantation |
| 111 | Bradley G. Brewer | M.S. | 2002 | Peter P. Rowell, Ph.D. | Short-term distribution of nicotine in the rat |
| 110 | Xia (Clare) Shen | M.S. | 2002 | Paul N. Epstein, Ph.D. | Proteomics and morphology demonstrate mitochondrial changes in diabetic cardiomyopathy |
| 109 | Hana H. Khaled | M.S. | 2002 | William M. Pierce Jr., Ph.D. | Osteoporosis: An overview of prevention, genetics, and treatment |
| 108 | Hainan Chen | M.S. | 2002 | Paul N. Epstein, Ph.D. | Metallothionein protection against streptozotocin induced pancreatic beta cell damage and diabetes |
| 107 | Jason R. Neale | Ph.D. | 2002 | William M. Pierce Jr., Ph.D. | Bone-targeted estrogens: Structure-activity relationships and mechanistic studies |
| 106 | Jian Li | M.S. | 2002 | John W. Eaton, Ph.D. | Mitochondrial metabolism and oxygen toxicity |
| 105 | Yining Hou | Ph.D. | 2002 | Nicholas A. Delamere, Ph.D. | The influence of cytoplasmic calcium on H+-ATPase; and the influence of H+-ATPase inhibition on sodium transport in non-pigmented ciliary epithelial cells |
| 104 | Alfred A. Jacobs, Jr. | Ph.D. | 2001 | Michael E. Brier, Ph.D. | Influence of cyclosporin on renal hemodynamics in the isolated perfused kidney |
| 103 | Jason C. Lambert | M.S. | 2001 | Y. James Kang, Ph.D. | Zinc inhibition of caspase-3 activation does not prevent apoptotic cell death |
| 102 | E. Cristian Campian | M.S. | 2001 | Frederick W. Benz, Ph.D. | Acute acrylonitrile toxicity: inhibition of glyceraldehyde- 3-phosphate dehydrogenase activity in vitro |
| 101 | Laila Elsherif | M.S. | 2001 | Y. James Kang, Ph.D. | Metallothionein protection against cadmium cardiotoxicity |
| 100 | R. Scot Payne | Ph.D. | 2001 | Avital Schurr, Ph.D. | The corticosterone hypothesis of hyperglycemia-enhanced cerebral ischemic damage |
| 99 | Xin Fu | Ph.D. | 2001 | Walter M. Williams, M.D., Ph.D. | Para-Aminophenol-induced hepatotoxicity in hamsters |
| 98 | Xichun Sun | Ph.D. | 2001 | Y. James Kang, Ph.D. | Metallothionein protection of the heart from ischemia/reperfusion injury: Cellular and molecular mechanisms |
| 97 | John P. Hennion | M.S. | 2001 | Rif El-Mallakh, M.D. | Evaluation of neuroprotection by lithium and valproic acid against ouabain-induced cell damage |
| 96 | April K. Hartford | M.S. | 2000 | Nicholas A. Delamere, Ph.D. | Calcium signaling in astrocytes of the optic nerve head; Evidence for a role for Na,K-ATPase Alpha-2 |
| 95 | Jason R. Neale | M.S. | 2000 | William M. Pierce Jr., Ph.D. | A novel bone selective estrogen: A candidate compound for the treatment of osteopenia |
| 94 | Adrian J. Fretland | Ph.D. | 2000 | David W. Hein, Ph.D. | Pharmacogenetics of heterocyclic amine carcinogenesis |
| 93 | Joseph A. Spinnato, III | Ph.D. | 1999 | Steven R. Myers, Ph.D | Microsomal metabolism and tissue distribution of N-Methyl-N-2,4,6-tetranitroaniline (tetryl) |
| 92 | Matthew A. Leff | Ph.D. | 1999 | David W. Hein, Ph.D. | Molecular genetics of N-acetyltransferases and prostate cancer |
| 91 | Jian Cai | Ph.D. | 1999 | Harrell E. Hurst, Ph.D. | N-(carboxymethyl)valine adduct in hemoglobin: A biomarker of advanced glycation end product formation and oxidative stress |
| 90 | Jungyu Li | Ph.D. | 1999 | Frederick W. Benz, Ph.D. | Acrylonitrile acute intoxication: Toxicodynamics and the effects of antidotes |
| 89 | Nicolas Melo | M.S. | 1999 | Walter M. Williams, M.D., Ph.D. | Prevention of acetaminophen-induced hepatotoxicity by S-(2-hydroxyethylmercapto)-L-cysteine |
| 88 | David A. Hasselbacher | M.S. | 1998 | George R. Aronoff, M.D. | The development of a dosing model for the anticoagulant heparin using neural networks |
| 87 | Emiko Lynn Kreklau | Ph.D. | 1997 | Y. James Kang, Ph.D. | Cross-resistance to adriamycin in cadium-resistant human lung carcinoma A549 cells |
| 86 | Qiang Wu | Ph.D. | 1997 | Nicholas A. Delamere, Ph.D. | Studies of carbonic anhydrases and intracellular pH regulation in non-pigmented ciliary epithelial cells |
| 85 | Mary Manlei Li | Ph.D. | 1997 | Avital Schurr, Ph.D. | Global cerebral ischemia and neuroprotection |
| 84 | Sue Han | Ph.D. | 1997 | Laurence A. Carr, Ph.D. | Regulation of the dopamine neuronal transporter in the striatum |
| 83 | Chandrika Srinivasan | Ph.D. | 1997 | Theresa S. Chen, Ph.D. | Prevention of acetylaminophen-induced toxicity by n-propylthiazolidine carboxylic acid |
| 82 | Yining Hou | M.S. | 1997 | Nicholas A. Delamere, Ph.D. | Solutes transport mechanism in nonpigmented ciliary epithelium: influence of ascorbic acid uptake on sodium transport |
| 81 | Maureen Li | Ph.D. | 1996 | Peter P. Rowell, Ph.D. | Effect of chronic nicotine treatment on rat brain nicotine acetylcholine receptors |
| 80 | Ray Kemper | Ph.D. | 1995 | Harrell E. Hurst, Ph.D. | Effects of xenobiotic induction in metabolic activation and detoxification of ethyl carbamate |
| 79 | Hong Song | Ph.D. | 1994 | Theresa S. Chen, Ph.D. | Mouse and rat differences in p-aminophenol-induced liver and kidney toxicities |
| 78 | Jing Dong | Ph.D. | 1994 | Nicholas A. Delamere, Ph.D. | Solute transport mechanism in non-pigmented ciliary epithelium |
| 77 | Yun Meng | Ph.D. | 1994 | Walter M. Williams, M.D., Ph.D. | Elimination of uridine, thymidine and thymine by the isolated perfused rat liver |
| 76 | David B. Gazak | Ph.D. | 1993 | Walter M. Williams, M.D., Ph.D. | Pharmacological modulation of hepatic pyrimidine metabolism |
| 75 | Cathy Ann Rouze Spigarelli | M.S. | 1993 | Carlo Tamburro, M.D. | An investigation of nickel toxicity: an invitro study with escherichia coli |
| 74 | Di Chen | Ph.D. | 1992 | William M. Pierce Jr., Ph.D. | Effects of zinc on bone metabolism |
| 73 | Qusai Al-Mahasneh | M.S. | 1991 | George R. Rodgers, M.D., Ph.D. | The role of activated charcoal in the treatment of acute arsenic poisoning: an in vivo study |
| 72 | Mary Kathleen King Kaysinger | Ph.D. | 1991 | William M. Pierce Jr., Ph.D. | Regulation of bone prolyl-4-hydroxylase activity by 2-oxoglutarate |
| 71 | Rachelle J. Sells Galvin | Ph.D. | 1990 | Warren K. Ramp, Ph.D. | Effects of prolyhydroxylase inhibitors extracted from tobacco on bone collagen synthesis |
| 70 | Mordechai Sharir | Ph.D. | 1990 | William M. Pierce Jr., Ph.D. | Novel thiadiazole sulfonamide carbonic anhydrase inhibitors as topically effective ocular hypotensive agents (glaucoma) |
| 69 | Chong Zhang | Ph.D. | 1990 | Guandershan Thind, M.D. | Effects of cadmium on the renal and skeletal muscle microcirculation in rats |
| 68 | James M. Joly II | Ph.D. | 1989 | Walter M. Williams, M.D., Ph.D. | Elimination of 5-ethylpyridimidines and 5-methylpyrimidines by the isolated perfused rat liver |
| 67 | Mark J. Klan | Ph.D. | 1988 | Donald E. Nerland, Ph.D. | Microsomal carbinol dehydrogenase: isolation and possible role in xenobiotic toxicity |
| 66 | Karl G. Csaky | Ph.D. | 1987 | Walter M. Williams, M.D., Ph.D. | Metabolism of fluorodeoxyuridine by the isolated perfused rat liver |
| 65 | Charles R. Ashby, Jr. | Ph.D. | 1987 | Laurence A. Carr, Ph.D. | Alteration of serotoninergic mechanisms in premenstrual syndrome (PMS) |
| 64 | Elizabeth D. Dunlap | Ph.D. | 1987 | Michael A. Pfeifer, M.D. | Biochemical and physiological change associated with diabetes in the diabetic BB rat |
| 63 | Fu-Hsiung Lin | Ph.D. | 1987 | Walter M. Williams, M.D., Ph.D. | Fluorodeoxyuridine catabolism by isolated intestinal and tumor cells |
| 62 | John J. Schlager | Ph.D. | 1987 | Harrell E. Hurst, Ph.D. | Elimination of acetaminophen by the isolated perfused rat liver in the absence and presence of ethanol |
| 61 | Michael S. Wells | Ph.D. | 1986 | Donald E. Nerland, Ph.D. | Benzene metabolism and toxicity after inhalation exposure: analysis at steady-state |
| 60 | Donald E. Walters | Ph.D. | 1986 | Laurence A. Carr, Ph.D. | Neurochemical development in the rat following perinatal exposure to marihuana |
| 59 | Frank LaCreta | Ph.D. | 1986 | Walter M. Williams, M.D., Ph.D. | Effect of nucleoside phosphorylase inhibitors on hepatic fluoropyridmidine elimination |
| 58 | Ching-hsuen Chu | M.S. | 1986 | Warren K. Ramp, Ph.D. | The interrelationships of calcium release and glucose metabolism in bone |
| 57 | Cynthia L. Wabner | Ph.D. | 1986 | Theresa S. Chen, Ph.D. | Aging changes n renal function and structure |
| 56 | Barbour S. Warren | Ph.D. | 1985 | Walter M. Williams, M.D., Ph.D. | Fluoropyrimidine disposition: dose and flow dependence |
| 55 | Nancy A. Muma | Ph.D. | 1985 | Peter P. Rowell, Ph.D. | Pharmacological, biochemical, morphological and behavioral effects on long-term choline and lecithin administration on the aged central cholinergic nervous system |
| 54 | Brian J. Lukey | Ph.D. | 1985 | Harrell E. Hurst, Ph.D. | Predictors of plasma and tissue concentrations of nortriptyline and 10-OH metabolites |
| 53 | James A. Blank | Ph.D. | 1985 | Leonard C. Waite, Ph.D. | Calcium metabolism by the avian embryo |
| 52 | Michael J. Kelley | Ph.D. | 1984 | Theresa S. Chen, Ph.D. | Effects of 5-Thio-D-glucose on hexose transport and metabolism |
| 51 | Sayed Daoud | Ph.D. | 1984 | Kee Chang Huang, M.D., Ph.D. | Adriamycin: pharmacological studies on liver, kidney and heart |
| 50 | Brian J. Lukey | M.S. | 1983 | Harrell E. Hurst, Ph.D. | Sources of variability in plasma concentration measurements of nortriptyline and 10-hydroxylated metabolites |
| 49 | David R. Jones | Ph.D. | 1983 | Harrell E. Hurst, Ph.D. | Tissue distribution and toxicokinetics of nortriptyline |
| 48 | Michael W. McWilliams | M.S. | 1983 | Theresa S. Chen, Ph.D. | Preservation of microsomal enzyme activities in rat liver by WR-2721 following gamma-irradiation |
| 47 | Mostafa Z. Badr | Ph.D. | 1983 | Thomas G. Scharff, Ph.D. | Cellular penetration and toxicity of benzoic and salicyclic acids |
| 46 | Christopher J. Kemper | Ph.D. | 1983 | Donald E. Nerland, Ph.D. | Studies concerning the metabolism and kinetics of benzene in the mouse |
| 45 | Adrian B. VanBakel | Ph.D. | 1983 | William J. Waddell, M.D. | Renal vascular activity of bis substituted (3,4-dimethoxybenzyl)cycloalkylamine and heterocyclic amine hydrochlorides |
| 44 | Lois E. Bolcsak | Ph.D. | 1982 | Donald E. Nerland, Ph.D. | Benzene toxicity:emphasis on cytosolic dihydrodiol dehydrogenases |
| 43 | Stanley D. Erk | Ph.D. | 1982 | Charles H. Jarboe, Ph.D. | Toxicokinetic study of 1,2-propanediol dinitrate (PGDN) in the dog |
| 42 | Michael P. Lachance | Ph.D. | 1982 | William J. Waddell, M.D. | Whole-body localization of caffeine in the mouse |
| 41 | Mahmood H. Al-Wathiqui | Ph.D. | 1982 | William J. Waddell, M.D. | Effects of total parenteral nutrition on pharmacokinetics of drugs |
| 40 | Sonia R. Teller | Ph.D. | 1982 | Charles H. Jarboe, Ph.D. | Synthesis and peripheral cardiovascularization of cis- and trans-2-(3,4-dimethoxybenzyl)cycloalkylamine hydrochlorides |
| 39 | David R. Jones | M.S. | 1981 | Harrell E. Hurst, Ph.D. | Human pharmacokinetics of clovoxamine |
| 38 | William M. Pierce, Jr. | Ph.D. | 1981 | Leonard C. Waite, Ph.D. | Effects of heterocyclic sulfonamides on bone metabolism |
| 37 | Steven M. Leventer | Ph.D. | 1981 | Peter P. Rowell, Ph.D. | Investigations of the human placental cholinergic system |
| 36 | Raymond M. David | Ph.D. | 1981 | Donald E. Nerland, Ph.D. | Induction of hepatic glutathione S-transferase by ethanol |
| 35 | David C. May | Ph.D. | 1981 | Charles H. Jarboe, Ph.D. | Some aspects of rabbit and human methylxanthine pharmacokinetics |
| 34 | Maralyn E. Kaufman | Ph.D. | 1980 | Kee Chang Huang, M.D., Ph.D. | Effects of glucagon on the electrical and transport properties of the intestine |
| 33 | Harriet Tobias | Ph.D. | 1980 | Laurence A. Carr, Ph.D. | The interaction of gonadal steroids and catecholamine neurons on release of luteinizing hormone and prolactin |
| 32 | Margaret M. Schweri | Ph.D. | 1980 | Laurence A. Carr, Ph.D. | Inhibition of monoamine synthesis of cycloheximide and anisomycin: possible mechanisms of action |
| 31 | Gary E. Duncan | Ph.D. | 1980 | Peter P. Rowell, Ph.D. | The subcellular distribution and release of newly synthesized acetylcholine in rat cerebral cortical synaptosomes |
| 30 | Barbara Wenzak | Ph.D. | 1980 | Kee Chang Huang, M.D., Ph.D. | The renal excretion of methotrexate |
| 29 | Susan M. Wehry | M.S. | 1979 | Laurence A. Carr, Ph.D. | The effects of amnesic agents and d-amphetamine on brain catecholamines in two mouse strains |
| 28 | Michael J. Bannon | M.S. | 1978 | Charles H. Jarboe, Ph.D. | Central nervous system action of 2,5-bis-(3,4-dimethoxybenzyl)cyclopentyl amine, a peripheral dopamine blocking agent |
| 27 | Mark D. Lineberry | Ph.D. | 1978 | Leonard C. Waite, Ph.D. | Effects of carbonic anhydrase inhibitors on calcium metabolism |
| 26 | Paul H. Lungren | M.S. | 1978 | Laurence A. Carr, Ph.D. | The effects of anisomycin and central nervous stimulants on brain catecholamine synthesis |
| 25 | Andrew M. Connor | M.S. | 1975 | Curtis A. Sigdestad, Ph.D. | The enhancement of gamma radiation by procarbazine hydrochloride |
| 24 | Aaron E. Lucas | M.S. | 1974 | John A. Nicholson, Ph.D. | The effects of acute and chronic morphine administration on the cardiovascular system of the dog |
| 23 | Chung Sim Kim | M.S. | 1973 | Kee Chang Huang, M.D., Ph.D. | A cerebroventricular perfusion technique for studying L-tryrosine transport into the ventricle |
| 22 | James A. Schaefer | M.S. | 1973 | Charles H. Jarboe, Ph.D. | Some aspects of S-(-)-nicotine biochemorphology |
| 21 | Yun-Lai Chan | Ph.D. | 1971 | Kee Chang Huang, M.D., Ph.D. | Microperfusion and micropuncture studies of renal tubular transport of tryptophan derivatives |
| 20 | Theresa S.T. Chen | Ph.D. | 1971 | Kee Chang Huang, M.D., Ph.D. | Ion transport across the intestinal mucosa of fish |
| 19 | Walter M. Williams | Ph.D. | 1970 | Kee Chang Huang, M.D., Ph.D. | Structural specificity in the renal tubular transport of tryptophan derivatives |
| 18 | George P. Casten | Ph.D. | 1969 | Thomas G. Scharff, Ph.D. | Hexose-induced delay of hexose monophosphate fermentation in dialysed yeast extract |
| 17 | Gloria D. Sells | Ph.D. | 1969 | Kee Chang Huang, M.D., Ph.D. | Studies of the development of intestinal transport |
| 16 | John A. Nicholson | Ph.D. | 1969 | Charles H. Jarboe, Ph.D. | Pharmacological properties of viburnum |
| 15 | Patrick E. Bentley | Ph.D. | 1968 | Peter K. Knoefel, M.D. | Liberation of histamine as a mechanism of the toxic action of radiopaque diagnostic agents |
| 14 | Kenneth L. Bailey | Ph.D. | 1968 | Peter K. Knoefel, M.D. | Hippuric acid secretion in the mammalian kidney |
| 13 | Karimullah Abd Zirvi | Ph.D. | 1968 | Charles H. Jarboe, Ph.D. | Centrally active imides and amides of certain cyclobutanecarboxylic acids |
| 12 | Raymond L. Woosley | Ph.D. | 1967 | Kee Chang Huang, M.D., Ph.D. | Renal tubular transport of hexoses |
| 11 | David N. Johnson | M.S. | 1966 | Richard P. Smith, Ph.D. | The sympathetic innervation of the rabbit seminal vesicle |
| 10 | Mahmoud Oskoui | Ph.D. | 1965 | Peter K. Knoefel, M.D. | Nephrotic action of a synthetic plastic material and some of its constituents |
| 9 | Lin Min Chen | M.S. | 1965 | Paul G. LeFevre, Ph.D. | Reactions of red cell sugar transport system with non-transported analogues |
| 8 | Robert L. Moffitt | Ph.D. | 1964 | Thomas G. Scharff, Ph.D. | Reinvestigation of certain aspects of fermentation in yeast extracts |
| 7 | David Ling | M.S. | 1964 | Kee Chang Huang, M.D., Ph.D. | Biliary excretion of organic acids |
| 6 | Alan R. Kolber | Ph.D. | 1964 | Paul G. LeFevre, Ph.D. | Evidence for carrier-mediated transport of monosaccharides in the Ehrlich ascitis tumor cell |
| 5 | Linda Cohen | M.S. | 1963 | Kee Chang Huang, M.D., Ph.D. | Intestinal absorption of tryptophan and its derivatives |
| 4 | Hubert J. Wolfe | M.S. | 1959 | Kee Chang Huang, M.D., Ph.D. | The metabolism of the aminobenzoic acids in the adult and embryonic gallus domesticus |
| 3 | James W. Fisher | Ph.D. | 1958 | Peter K. Knoefel, M.D. | The influence of the adrenocortical hormones on cobalt polycythemia |
| 2 | Frederic E. Shaffer | M.S. | 1945 | A. James Miller, Ph.D. & Peter K. Knoefel, M.D. | Studies on spinal anesthesia |
| 1 | Herbert J. Brinker | M.S. | 1937 | George E. Wakerlin, M.D., Ph.D. |
Facebook
Twitter
Linkedin